Avanos Medical, Inc. (AVNS) is a Medical - Devices company in the Healthcare sector, currently trading at $24.63. It has a SharesGrow Score of 32/100, indicating a weak investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of AVNS = $113.83 (+362.2% from the current price, the stock appears undervalued). Analyst consensus target is AVNS = $23 (-6.6% upside).
Valuation: AVNS trades at a trailing Price-to-Earnings (P/E) of -9.5 (S&P 500 average ~25).
Financials: revenue is $701M, -4.6%/yr average growth. Net income is $68M (loss), growing at -224.7%/yr. Net profit margin is -9.7% (negative). Gross margin is 49.8% (-5.1 pp trend).
Balance sheet: total debt is $129M against $778M equity (Debt-to-Equity (D/E) ratio 0.17, conservative). Current ratio is 2.15 (strong liquidity). Debt-to-assets is 12%. Total assets: $1.1B.
Analyst outlook: 1 / 8 analysts rate AVNS as buy (13%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 35/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 67/100 (Partial), Moat 48/100 (Partial), Future 26/100 (Fail), Income 10/100 (Fail).
